21 Jan 2019 14:20
Â
Â
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
Â
Â
21 January 2019
Accrol Group Holdings plc
("Accrol" or the "Company")
AIM: ACRL
Â
Regulatory Investigation
Â
The Financial Conduct Authority (the "FCA") has notified Accrol that it has commenced an investigation into the Company relating to certain statements that it made to the market between 1 April 2017 and 20 November 2017. Accrol is cooperating fully with the FCA.
Â
The Company will issue its Half Year Results for the six months ended 31 October 2019 tomorrow, as previously announced.
Â
For further information, please contact: | Â |
 |  |
Accrol Group Holdings plc | Â |
Dan Wright, Executive Chairman | Tel: +44 (0) 1254 278 844 |
Gareth Jenkins, Chief Executive Officer | Â |
 |  |
Zeus Capital Limited (Nominated Adviser & Broker)Â | Â |
Dan Bate / Andrew Jones | Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold | Tel: +44 (0) 203 829 5000 |
 |  |
Belvedere Communications Limited | Â |
Cat Valentine (cvalentine@belvederepr.com) | Tel: +44 (0) 7715 769 078 |
Keeley Clarke (kclarke@belvederepr.com) | Tel: +44 (0) 7967 816 525 |
Â
Notes to Editors
Â
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.Â
Â
Accrol operates from three sites:
Â
· A manufacturing, storage and distribution facility in Blackburn;
· A facial tissue plant, also in Blackburn; and
· A manufacturing, storage and distribution facility in Leyland.
Â
Â
Â